Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Clementia Pharmaceuticals Inc. obtains interim order for proposed transaction with Ipsen S.A. and enters into support and voting agreements with two additional significant shareholders

firstwordpharmaMarch 07, 2019

Tag: Clementia Pharmaceuticals , obtains , significant shareholders

PharmaSources Customer Service